146 related articles for article (PubMed ID: 37603323)
1. Development of a rabbit human glioblastoma model for testing of endovascular selective intra-arterial infusion (ESIA) of novel stem cell-based therapeutics.
Kan P; Srinivasan VM; Gumin J; Garcia R; Chen SR; Johnson JN; Collins DE; Chen MM; Ledbetter D; Huse J; Evan Luna ZA; Robledo A; Vasandani V; Rao A; Singh SK; Shpall EJ; Fueyo J; Gomez-Manzano C; Lang FF
Neuro Oncol; 2024 Jan; 26(1):127-136. PubMed ID: 37603323
[TBL] [Abstract][Full Text] [Related]
2. Endovascular Selective Intra-Arterial Infusion of Mesenchymal Stem Cells Loaded With Delta-24 in a Canine Model.
Srinivasan VM; Gumin J; Camstra KM; Collins DE; Chen MM; Shpall EJ; Parker Kerrigan BC; Johnson JN; Chen SR; Fueyo J; Gomez-Manzano C; Lang FF; Kan P
Neurosurgery; 2020 Dec; 88(1):E102-E113. PubMed ID: 33231254
[TBL] [Abstract][Full Text] [Related]
3. Perfusion-guided endovascular super-selective intra-arterial infusion for treatment of malignant brain tumors.
Chen SR; Chen MM; Ene C; Lang FF; Kan P
J Neurointerv Surg; 2022 Jun; 14(6):533-538. PubMed ID: 34824133
[TBL] [Abstract][Full Text] [Related]
4. Advances in endovascular neuro-oncology: endovascular selective intra-arterial (ESIA) infusion of targeted biologic therapy for brain tumors.
Srinivasan VM; Lang FF; Chen SR; Chen MM; Gumin J; Johnson J; Burkhardt JK; Kan P
J Neurointerv Surg; 2020 Feb; 12(2):197-203. PubMed ID: 31676690
[TBL] [Abstract][Full Text] [Related]
5. Rabbit Model of Human Gliomas: Implications for Intra-Arterial Drug Delivery.
Qin H; Janowski M; Pearl MS; Malysz-Cymborska I; Li S; Eberhart CG; Walczak P
PLoS One; 2017; 12(1):e0169656. PubMed ID: 28103265
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
7. A murine model of targeted infusion for intracranial tumors.
Kim M; Barone TA; Fedtsova N; Gleiberman A; Wilfong CD; Alosi JA; Plunkett RJ; Gudkov A; Skitzki JJ
J Neurooncol; 2016 Jan; 126(1):37-45. PubMed ID: 26376657
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor efficacy of low-dose Etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenografts.
Cheema TA; Kanai R; Kim GW; Wakimoto H; Passer B; Rabkin SD; Martuza RL
Clin Cancer Res; 2011 Dec; 17(23):7383-93. PubMed ID: 21976549
[TBL] [Abstract][Full Text] [Related]
9. MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors.
Yacoub A; Hamed H; Emdad L; Dos Santos W; Gupta P; Broaddus WC; Ramakrishnan V; Sarkar D; Shah K; Curiel DT; Grant S; Fisher PB; Dent P
Cancer Biol Ther; 2008 Jun; 7(6):917-33. PubMed ID: 18376144
[TBL] [Abstract][Full Text] [Related]
10. Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.
Rimkus TK; Carpenter RL; Sirkisoon S; Zhu D; Pasche BC; Chan MD; Lesser GJ; Tatter SB; Watabe K; Debinski W; Lo HW
Cancer Res; 2018 May; 78(10):2589-2600. PubMed ID: 29463580
[TBL] [Abstract][Full Text] [Related]
11. Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cells.
Srinivasan VM; Gumin J; Camstra KM; Chen SR; Johnson JN; Shimizu Y; Parker Kerrigan BC; Shpall EJ; Lang FF; Kan P
J Neurosurg; 2019 Sep; 133(4):1182-1190. PubMed ID: 31491769
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms and Antitumor Activity of a Binary EGFR/DNA-Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide.
Sharifi Z; Abdulkarim B; Meehan B; Rak J; Daniel P; Schmitt J; Lauzon N; Eppert K; Duncan HM; Petrecca K; Guiot MC; Jean-Claude B; Sabri S
Clin Cancer Res; 2019 Dec; 25(24):7594-7608. PubMed ID: 31540977
[TBL] [Abstract][Full Text] [Related]
13. The first endovascular rat glioma model for pre-clinical evaluation of intra-arterial therapeutics.
Lim J; Baig AA; Donnelly BM; Chaves LD; Pol SU; Koenigsknecht C; Pionessa D; Levy BR; Gutierrez L; Tutino VM; Levy EI; Siddiqui AH
Interv Neuroradiol; 2023 May; ():15910199231169597. PubMed ID: 37157800
[TBL] [Abstract][Full Text] [Related]
14. Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood-brain barrier disruption: where are we now, and where we are going.
D'Amico RS; Khatri D; Reichman N; Patel NV; Wong T; Fralin SR; Li M; Ellis JA; Ortiz R; Langer DJ; Boockvar JA
J Neurooncol; 2020 Apr; 147(2):261-278. PubMed ID: 32076934
[TBL] [Abstract][Full Text] [Related]
15. Ionizing radiation augments glioma tropism of mesenchymal stem cells.
Thomas JG; Parker Kerrigan BC; Hossain A; Gumin J; Shinojima N; Nwajei F; Ezhilarasan R; Love P; Sulman EP; Lang FF
J Neurosurg; 2018 Jan; 128(1):287-295. PubMed ID: 28362237
[TBL] [Abstract][Full Text] [Related]
16. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
Ozawa Y; Yamamuro S; Sano E; Tatsuoka J; Hanashima Y; Yoshimura S; Sumi K; Hara H; Nakayama T; Suzuki Y; Yoshino A
Biochem Biophys Res Commun; 2020 Apr; 524(3):723-729. PubMed ID: 32035622
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
Wakimoto H; Mohapatra G; Kanai R; Curry WT; Yip S; Nitta M; Patel AP; Barnard ZR; Stemmer-Rachamimov AO; Louis DN; Martuza RL; Rabkin SD
Neuro Oncol; 2012 Feb; 14(2):132-44. PubMed ID: 22067563
[TBL] [Abstract][Full Text] [Related]
18. Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology.
Vieira de Castro J; Gomes ED; Granja S; Anjo SI; Baltazar F; Manadas B; Salgado AJ; Costa BM
J Transl Med; 2017 Oct; 15(1):200. PubMed ID: 28969635
[TBL] [Abstract][Full Text] [Related]
19. Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts.
Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; Coccè V; Bonomi A; Buccarelli M; Pascucci L; Alessandri G; Pessina A; Ricci-Vitiani L; Falchetti ML; Pallini R
Stem Cell Res Ther; 2017 Mar; 8(1):53. PubMed ID: 28279193
[TBL] [Abstract][Full Text] [Related]
20. Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma.
Shimizu Y; Gumin J; Gao F; Hossain A; Shpall EJ; Kondo A; Parker Kerrigan BC; Yang J; Ledbetter D; Fueyo J; Gomez-Manzano C; Lang FF
J Neurosurg; 2022 Mar; 136(3):757-767. PubMed ID: 34450587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
